StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Goldman Sachs Reiterates Buy Rating on Abbott Labs (ABT)
July 17, 2025 9:45 AM
Goldman Sachs analyst David Roman reiterated a Buy rating and $153.00 price target on Abbott Labs (NYSE: ABT).The analyst comments ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
Abbott Labs (ABT) PT Lowered to $155 at Citi
July 18, 2025 10:03 AM
Form 8-K ABBOTT LABORATORIES For: Jul 17
July 17, 2025 7:35 AM
Abbott flags over $1 billion hit in 2025 from tariffs, COVID test decline
July 17, 2025 7:33 AM
Abbott (ABT) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY25 EPS Guidance
July 17, 2025 7:31 AM
Abbott Reports Second-Quarter 2025 Results
July 17, 2025 7:30 AM
Abbott (ABT) option IV bid into quarter results
July 16, 2025 11:19 AM
Abbott Labs (ABT) PT Raised at RBC Capital Following Recent Stock Performance
July 15, 2025 9:38 AM
Piper Sandler Reiterates Overweight Rating on Abbott Labs (ABT)
July 15, 2025 9:03 AM
Abbott Labs (ABT) PT Raised to $137 at Morgan Stanley
July 15, 2025 8:26 AM
Abbott Labs (ABT) PT Raised to $140 at Mizuho
July 15, 2025 6:58 AM
